학술논문
The Risk of Necrotizing Enterocolitis following the Administration of Hyperosmolar Enteral Medications to Extremely Preterm Infants
Document Type
Report
Author
Source
Neonatology. March 1, 2021, Vol. 118 Issue 1, p73, 7 p.
Subject
Language
English
ISSN
1661-7800
Abstract
Introduction: Necrotizing enterocolitis (NEC) is a disease predominantly affecting preterm infants. The administration of hyperosmolar solutions could lead to the development of NEC. The objective of this study was to measure the osmolality of enteral medications used in clinical practice and to assess the risk of NEC following exposure to hyperosmolar medications. Methods: A retrospective cohort study in extremely preterm infants (gestational age Keywords: Osmolality, Extremely preterm infant, Oral medication, Necrotizing enterocolitis, Safety
Author(s): Faiza Latheef (corresponding author) [a,b]; Hanna Wahlgren [a]; Helene Engstrand Lilja [a]; Barbro Diderholm [a]; Mattias Paulsson [a] Introduction Necrotizing enterocolitis (NEC) is the most serious gastrointestinal disease affecting [...]
Author(s): Faiza Latheef (corresponding author) [a,b]; Hanna Wahlgren [a]; Helene Engstrand Lilja [a]; Barbro Diderholm [a]; Mattias Paulsson [a] Introduction Necrotizing enterocolitis (NEC) is the most serious gastrointestinal disease affecting [...]